New York, New York (PRWEB) November 06, 2013
Hundreds of Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) involving recalled Rejuvenate and ABG II Modular-Neck hip stems continue to move forward in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to court documents, the Court issued a new Implementing Order on October 23, 2013 pertaining to the Defendant Fact Sheet to be used in the proceeding. Among other things, the Order directed the parties in the Stryker hip recall litigation to meet and confer to determine an appropriate schedule for the rolling production of Defendant Fact Sheets. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm is pleased with the progress in this proceeding thus far, as we are representing numerous Stryker hip lawsuit clients who have claims pending in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who were allegedly affected by the July 2012 Stryker hip recall for Rejuvenate and ABG II hip stems.
Stryker Hip Recall
Court documents indicate that at least 433 Stryker hip lawsuits were pending in the New Jersey litigation as of October 23rd. All of the lawsuits filed in the proceeding allege that fretting and corrosion of the metal components caused plaintiffs to suffer a variety of serious complications, including metallosis, adverse local tissue reactions, necrosis, osteolysis, and failure of the hip, often resulting in revision surgery to replace the device. According to court records, a small number of Stryker lawsuits filed in Bergen County have been selected for early mediation, and the Court has directed that a mediation session be held no later than December 15, 2013.
Court documents filed in U.S. District Court, District of Minnesota, indicate that at least 346 additional Stryker hip recall claims involving similar allegations have been filed in that jurisdiction. The next Status Conference in the federal proceeding is scheduled for November 21, 2013. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Rejuvenate and ABG II hip stems were subject to the Stryker hip recall on July 6, 2012, after post-market surveillance data indicated the components were vulnerable to fretting and corrosion at the modular-neck junction. According to Stryker, metal ions released due to this process could cause recipients of Rejuvenate and ABG II hip stems to experience pain, swelling and adverse local tissue reactions which may require revision surgery to replace the failing hip. Stryker has advised all Rejuvenate and ABG II recipients to undergo blood testing and cross sectional imaging, regardless of their symptoms, to ensure the hips are functioning properly.*
Individuals who may have been affected by the Stryker hip recall could be eligible to receive compensation for medical bills, lost wages, pain and suffering and other damages.Learn More about the complications that may be associated with these Stryker hip implants at Bernstein Liebhard LLP’s website. For a free review of your potential Stryker hip lawsuit, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP